Genvor 10-Q Reveals $1.6M Tax Reimbursement Liability and New Material Weaknesses
Summary
Genvor's Q3 10-Q reveals a $1.65M tax reimbursement liability, new material weaknesses, and continued going concern doubts, with only $196,522 in cash.
Key Events · Earnings and Guidance · GNVR
-
Tax Reimbursement Policy Liability
Board approved a policy retroactive to January 1, 2024, resulting in a $1,646,487 liability and $1,567,919 of additional operating expense in Q3 2026.
-
New Material Weaknesses
Management identified additional material weaknesses in internal control over financial reporting related to tax filing, reporting, and withholding obligations.
-
Going Concern Doubts
With only $196,522 in cash and a working capital deficit of $2,551,952, the company reiterates substantial doubt about its ability to continue as a going concern.
-
Series C Preferred Stock Issuance
Issued 3 shares of Series C Preferred Stock to Brio Advisory Group LLC for advisory services, valued at $381,641.
Analysis · GNVR · Industrial Applications And Services
Genvor's Q3 10-Q discloses a board-approved tax reimbursement policy retroactive to January 2024, creating a $1.65 million liability and $1.57 million in additional operating expenses. The filing also identifies new material weaknesses in internal controls related to tax filings, adding to existing going concern and control deficiencies. These are significant governance and financial red flags for a company with only $196,522 in cash and no revenue.
How filings like this one have moved
In the 30 days to Sep 16, 2026, 35.4% of the 1170 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.43%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, GNVR was trading at $0.55 on OTC in the Industrial Applications And Services sector. The 52-week trading range was $0.00 to $10.01. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.